On May 26, six A-share listed companies, including Buchang Pharmaceutical, Treasure Island, and Jiayou International, revealed their repurchase plans. It is worth noting that among them, Buchang Pharmaceutical initiated a repurchase for the second time in the year, and the repurchase plan announced by the company in January was completed in February. In fact, Buchang Pharmaceutical has carried out multiple share repurchases, which is also a microcosm of the current repurchase boom of A-share listed companies. According to Wind statistics, up to now, 578 A-share listed companies have disclosed 633 repurchase plans since this year, with a total proposed repurchase amount of 105.698 billion yuan.

On May 26, six A-share listed companies, including Buchang Pharmaceutical, Treasure Island, and Jiayou International, revealed their repurchase plans. It is worth noting that among them, Buchang Pharmaceutical initiated a repurchase for the second time in the year, and the repurchase plan announced by the company in January was completed in February. In fact, Buchang Pharmaceutical has carried out multiple share repurchases, which is also a microcosm of the current repurchase boom of A-share listed companies. According to Wind statistics, up to now, 578 A-share listed companies have disclosed 633 repurchase plans since this year, with a total proposed repurchase amount of 105.698 billion yuan.